E
Exact Sciences Corp D
D
EXAS
58.300
USD
-1.18
(-1.98%)
مغلق
حجم التداول
81,840
الربح لكل سهم
-1
العائد الربحي
-
P/E
-11
حجم السوق
11,037,304,113
العنوان: Exact Sciences Corp
القطاع: Healthcare
الصناعة: Diagnostics & Research
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, aliquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.